EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome

Per Venge iD, Valeria Castro Tejera, Christer Petersson, Shengyuan Xu, Anders Larsson, Magnus Simrén, Lena Öhman, Hans Törnblom iD

Neurogastroenterology & Motility · 2025

DOI: 10.1111/nmo.14984 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neurogastroenterology & Motility, 2025. Verfasst von Per Venge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Uppsala University and Diagnostics Development, Uppsala, Sweden. Hauptthemen laut MEDLINE: Colon, Epithelial Cells, Feces, Intestinal Mucosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Irritable bowel syndrome (IBS) is a common functional gastro‐intestinal disorder characterized by discomfort with constipation and/or diarrhea with unclear pathophysiology. We aimed to determine the activities of colorectal eosinophils, neutrophils and epithelial cells by biomarkers in feces reflecting these activities.

Methods

Fecal samples were collected from 185 patients with IBS before and after 8 weeks of placebo or mesalazine treatment and from 40 healthy subjects. Calprotectin, eosinophil derived neurotoxin (EDN), eosinophil cationic protein (ECP), human neutrophil lipocalin (HNL) (pab/765) or dimer, human phospholipase BII‐precursor (HPLBII‐P) and myeloperoxidase (MPO) were measured by ELISA. Symptom scores were evaluated by diaries.

Results

HPLBII‐P, HNL (pab/765) and EDN, proteins secreted by intestinal epithelial cells, were elevated in IBS patients as compared to healthy subjects ( p < 0.0001– p = 0.008). In contrast, the neutrophil proteins calprotectin, MPO and HNL dimer were unaltered. The eosinophilic protein ECP was lower in IBS ( p = 0.001). HNL (pab/765) ( p = 0.01) and EDN ( p = 0.004) increased in IBS patients after mesalazine treatment. Colo‐rectal mucosa showed strong staining of HPLBII‐P and western blotting of fecal extracts showed the presence of mainly monomeric, epithelial‐associated HNL.

Conclusions

The absence of signs of involvement of neutrophils and eosinophils in IBS suggests that activity of local epithelial cells rather than inflammation may be a major determinant of the disease. The measurements of EDN, HNL (pab/765), and HPLBII‐P may serve as potential fecal biomarkers in the study and monitoring of IBS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColonEpithelial CellsFecesIntestinal MucosaIrritable Bowel SyndromeRectumAdultAgedFemaleHumansMaleMiddle AgedYoung AdultBiomarkersEosinophil Cationic ProteinEosinophil-Derived NeurotoxinEosinophilsLeukocyte L1 Antigen ComplexMesalamineNeutrophils

Stichwörter der Autor:innen

calprotectineosinophileosinophil cationic proteineosinophil derived neurotoxinhuman neutrophil lipocalinmyeloperoxidaseneutrophil

Substanzen

BiomarkersEosinophil Cationic ProteinEosinophil-Derived NeurotoxinLeukocyte L1 Antigen ComplexMesalamine

Autor:innen und Institutionen

  • Department of Medical Sciences, Uppsala University and Diagnostics Development, Uppsala, Sweden.
  • Diagnostics Development, Uppsala, Sweden.
  • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Center for Functional GI and Motility Disorders, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Per Venge, Hans Törnblom

Zitieren

APA

Venge, P., Tejera, V. C., Petersson, C., Xu, S., Larsson, A., Simrén, M., Öhman, L., & Törnblom, H. (2025). Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14984

Vancouver

Venge P, Tejera VC, Petersson C, Xu S, Larsson A, Simrén M, et al. Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome. Neurogastroenterology & Motility. 2025. doi:10.1111/nmo.14984

BibTeX
@article{Venge2025,
  author = {Venge, Per and Tejera, Valeria Castro and Petersson, Christer and Xu, Shengyuan and Larsson, Anders and Simrén, Magnus and Öhman, Lena and Törnblom, Hans},
  title = {Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  doi = {10.1111/nmo.14984}
}
Kostenlos starten →